Actavia Life Sciences (Actavia Life Sciences) 3-Year EBITDA Growth Rate : 55.00% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Actavia Life Sciences 3-Year EBITDA Growth Rate?

Actavia Life Sciences's EBITDA per Share for the three months ended in Dec. 2023 was $0.00.

During the past 12 months, Actavia Life Sciences's average EBITDA Per Share Growth Rate was -800.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 55.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Actavia Life Sciences was 56.10% per year. The lowest was -289.30% per year. And the median was -29.40% per year.

Competitive Comparison of Actavia Life Sciences's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Actavia Life Sciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actavia Life Sciences's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actavia Life Sciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Actavia Life Sciences's 3-Year EBITDA Growth Rate falls into.

Actavia Life Sciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Actavia Life Sciences (OTCPK:RASP) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Actavia Life Sciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Actavia Life Sciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Actavia Life Sciences (Actavia Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actavia Life Sciences Inc (OTCPK:RASP) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 Lexington Avenue, Suite 2525, New York, NY, USA, 10170

Website

https://www.rasna.com

Rasna Therapeutics Inc is a clinical-stage biotechnology company focused on targeted drugs to treat diseases in oncology and immunology, mainly focusing on the treatment of leukemia. Its primary indication is Acute Myeloid Leukemia (AML), which may be fatal within weeks to months, has about a 5-year survival rate of only about 25% and very poor prospects for the long-term survival of patients.

Actavia Life Sciences (Actavia Life Sciences) Headlines

No Headlines